Cardiologs, a company that specializes in AI cardiology diagnostics, today announced the launch of Cardiologs RPM, an offering it says, “unlocks the potential of smartwatches for remote cardiac patient monitoring.”

The platform is the company's first venture into the remote patient monitoring space, bringing its foundational ECG analysis tool to a more direct level of patient care with the goal of going beyond the world of arrhythmias, it said.

“A growing number of smartwatches are now capable of capturing an ECG, and older adults are increasingly using them to monitor a variety of aspects about their personal health,” a release stated. “Devices such as the Apple Watch are approved by the FDA as cardiac monitors that can be used to detect atrial fibrillation (AFib) and to better understand patients' symptoms.”

In a recent study involving Cardiologs AI, ECG data collected with smartwatches was also used to monitor QT-prolongation, a life-threatening heart rhythm disorder that is associated with more than 300 commonly-used drugs.

“It is an exciting trend to see patients embracing this technology, which has the potential to transform the traditional care pathway by enabling a much closer following of their condition,” said Dr. Jagmeet Singh, a cardiologist at Massachusetts General Hospital (MGH) and professor of medicine at Harvard Medical School.

“However, this places a burden on physicians like we have never seen before.”

According to a Cardiologs release, while “smartwatch users can easily take an ECG whenever they want, sharing and handling that information remains a challenge.

“Today, most patients have to manually send their ECG recordings in PDF format via email to their clinicians. The frequency with which patients can record and share results creates a fast-growing and overwhelming amount of data that is decentralized, untriaged and non-billable to analyze. The lack of data integration into the clinical workflow is a key reason why few cardiac professionals are ready to embrace smartwatch capabilities.”

Company founder and CEO Yann Fleureau, said that the unstructured and decentralized flow of clinical information is limiting smartwatches from making their way into clinical practice at scale.

“Our platform will address these challenges by automating and streamlining the data-sharing and data-reviewing process,” he said. “(It) will prioritize the data and information that needs the most attention, provide physicians with an efficient workflow to review ECG strips, and implement a billing mechanism to monetize time spent on analysis.”

The Cardiologs RPM platform contains a patient mobile app for secure, seamless and automatic ECG data transfer and patient engagement optimization and capabilities for a physician to centralize and triage data according to their clinical relevance, as well as streamline ECG review, the company said.